CIK: 1376491 - Address: C/O Replimune Group, Inc., 500 Unicorn Park Drive, Suite 303, Woburn, MA 10801
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/20/24 20:04
5/16/24
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOExec CBS-2456.470-38-21,487D
5/18/23 20:30
5/16/23
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOCEOS-32318.050-18-11,525D
5/18/22 19:00
5/16/22
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOCEOS-14114.590-10-11,401D
3/4/21 14:26
3/2/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsAstley-Sparke PhilipP7DS-1937.600-1-510D
1/19/21 21:53
1/14/21
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOCEOS.m-2,18843.760-50-41,255D
12/11/20 21:00
12/9/20
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOCEOS.m-2,17043.400-50-41,305D
1/30/20 21:39
1/30/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsAstley-Sparke PhilipP7DS-4859.230-1-126D
11/8/19 21:16
11/6/19
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOExec CBS-49317.010-29-21,355D
11/6/19 19:38
11/4/19
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOExec CBS-49417.030-29-21,384D
11/4/19 16:16
10/31/19
REPLReplimune Group, Inc.DEHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOExec CBS-24717.000-15-11,413D
9/25/19 16:31
9/23/19
REPLReplimune Group, Inc.MAHealthBioPrdBiological Products, (No DiagAstley-Sparke PhilipMADOExec CBS-24717.050-15-11,428D
8/5/19 12:21
8/1/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsAstley-Sparke PhilipP7DS-38860.120-6-497D
6/4/19 14:07
6/3/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsAstley-Sparke PhilipP7DS-38263.630-6-3113D
4/3/19 12:22
4/1/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsAstley-Sparke PhilipP7DS-35959.840-6-2419D
1/30/19 17:20
1/28/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsAstley-Sparke PhilipP7DS-3831.320-1-525D
12/6/18 09:38
12/3/18
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsAstley-Sparke PhilipP7DS-15230.390-5-1823D
1/31/18 10:39
1/29/18
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsAstley-Sparke PhilipP7DS-12118.530-7-1928D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact